A Certificate of Analysis (COA) for research-grade Oxytocin relies on Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS) to confirm sequence identity, structural purity, and freedom from endotoxins. PX1 Research provides lot-specific analytical documentation for all synthetic neuropeptide compounds to ensure precise, reproducible results across cellular and biochemical assays.
A Certificate of Analysis (COA) for research-grade Oxytocin relies on Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS) to confirm sequence identity, structural purity, and freedom from endotoxins. PX1 Research provides lot-specific analytical documentation for all synthetic neuropeptide compounds to ensure precise, reproducible results across cellular and biochemical assays.
A Certificate of Analysis (COA) for synthetic oxytocin provides primary empirical evidence regarding chemical identity, purity profile, and residual impurity concentrations. For investigative laboratories conducting rigorous analytical or cellular evaluations, relying on verified high-performance liquid chromatography (HPLC) chromatograms and mass spectrometry (MS) spectra is essential to eliminate confounding variable factors caused by truncated sequences, residual reagents, or peptide degradation products.
When inspecting a COA for the oxytocin research peptide, principal investigators should confirm that the reporting laboratory utilizes validated analytical parameters. A compliant COA documents the target peptide's theoretical molecular weight against the experimentally observed mass-to-charge ($m/z$) ratio, presents an unedited RP-HPLC chromatogram with integrated peak area percentages, reports moisture content via Karl Fischer titration, and details bacterial endotoxin levels assessed via Quantitative Chromogenic Limulus Amebocyte Lysate (LAL) testing.
Oxytocin is a nonapeptide neuropeptide possessing the amino acid sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, featuring an intramolecular disulfide bridge between Cys1 and Cys6. This cyclic structure creates a rigid loop conformation necessary for high-affinity binding to the oxytocin receptor (OXTR), a class A Rhodopsin-like G-protein coupled receptor (GPCR). In vitro ligand-binding assays demonstrate that any alteration in the disulfide bridge or C-terminal amidation significantly attenuates receptor binding affinity.
Upon ligand binding, the oxytocin receptor couples primarily to the $G_{\alpha q/11}$ subclass of heterotrimeric G-proteins. Preclinical signal transduction studies show that this binding event activates phospholipase C-beta (PLC-$\beta$), triggering the hydrolysis of phosphatidylinositol 4,5-bisphosphate ($PIP_2$) into inositol 1,4,5-trisphosphate ($IP_3$) and diacylglycerol (DAG). The resulting $IP_3$ generation stimulates rapid calcium mobilization from the endoplasmic reticulum into the cytosol, initiating downstream signaling cascades including protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) pathways.
In preclinical rodent models and central nervous system brain slice preparations, oxytocin serves as a benchmark tool for mapping neurochemical pathways involved in social recognition, pair bonding, anxiety-like responses, and stress modulation. Central administration studies in murine models demonstrate that OXTR activation within the paraventricular nucleus (PVN) of the hypothalamus, central nucleus of the amygdala, and nucleus accumbens modulates synaptic plasticity and neurotransmitter release, including gamma-aminobutyric acid (GABA) and dopamine.
In vitro electrophysiological experiments indicate that oxytocin receptor activation selectively enhances the signal-to-noise ratio of inhibitory neuronal firing in cortical networks. Researchers utilizing quantitative receptor autoradiography and fluorophore-conjugated ligands leverage high-purity oxytocin to map receptor density and binding kinetics across various central neural circuits, establishing foundational data for neurobiological research.
Beyond central neural pathways, oxytocin is widely investigated in peripheral cell culture systems, specifically primary vascular and uterine smooth muscle cell lines. In vitro cell signaling studies demonstrate that oxytocin-induced $G_{\alpha q/11}$ activation leads to rapid intracellular $Ca^{2+}$ oscillations. The transient increase in free cytosolic calcium activates calmodulin, which subsequently stimulates myosin light chain kinase (MLCK), triggering actin-myosin cross-bridge formation and cellular contraction.
Analytical researchers evaluating smooth-muscle cell models utilize oxytocin to study cross-talk between GPCR pathways and receptor tyrosine kinases. Data from preclinical cell assays indicate that oxytocin receptor signaling can stimulate cellular proliferation, hypertrophic responses, or anti-inflammatory signaling depending on receptor density and the specific intracellular microenvironment. Utilizing compounds verified via our analytical testing protocols ensures that observed calcium spikes stem solely from the intact active peptide sequence rather than contaminating fragments.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the standard method for establishing the chemical purity of synthetic oxytocin. Because synthetic peptide synthesis (SPPS) can generate closely related side-products—such as deletion sequences, oxidized methionine or cysteine species, and diastereomers—the chromatographic method must resolve complex mixtures effectively. The separation typically employs a C18 stationary phase with a silica matrix, utilized under acidic gradient conditions.
A standard analytical RP-HPLC run for oxytocin utilizes a mobile phase gradient consisting of Phase A (0.1% trifluoroacetic acid [TFA] in HPLC-grade water) and Phase B (0.1% TFA in acetonitrile). Detection is performed via UV spectrophotometry at 214 nm and 220 nm, corresponding to the absorption wavelength of the peptide backbone amide bonds. Purity is calculated by integrating the area under the curve (AUC) for the main oxytocin peak relative to the total area of all integrated peaks, with research-grade standards requiring $\ge 98.0\%$ purity.
While RP-HPLC establishes chromatographic purity, Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry is required to confirm exact molecular identity. Synthetic oxytocin has a monoisotopic molecular weight of 1006.44 Da and an average molecular mass of approximately 1007.19 Da. Mass spectral analysis confirms the presence of the primary $[M+H]^+$ ion peak at $m/z \approx 1007.2$, verifying accurate amino acid assembly and proper disulfide loop closure.
In addition to structural verification, cell culture and in vivo research protocols demand stringent control over bacterial endotoxins. Gram-negative bacterial lipopolysaccharides (LPS) can trigger non-specific inflammatory signaling in cell cultures, skewing experimental results. PX1 Research mandates Quantitative Chromogenic LAL testing for every lot, enforcing strict limits (typically $< 0.01 \text{ EU/\mu g}$) documented directly on our COAs. Researchers can review detailed standards within our endotoxin limit guidelines.
When designing comparative receptor-binding or pharmacological profiling studies, researchers frequently compare oxytocin against structurally related nonapeptides and synthetic analogs. The most prominent structural homolog is arginine vasopressin, which differs by only two amino acids (position 3 contains phenylalanine instead of isoleucine, and position 8 contains arginine instead of leucine). Despite high sequence homology, vasopressin demonstrates preferential affinity for $V_{1a}$, $V_{1b}$, and $V_2$ receptors, making comparative HPLC and bioassay testing critical to differentiate cross-receptor activity.
Additionally, laboratories evaluating long-acting analog behavior often utilize carbetocin analytical standards, a synthetic octapeptide analog featuring a thioether modification that increases enzymatic stability against aminopeptidases. In contrast, researchers studying broader melanocortin and central signaling networks may compare oxytocin's effects with cyclic peptide agonists such as the pt-141 research profile. Maintaining verified purity across all test reagents ensures that observed binding kinetics reflect distinct receptor selectivity rather than cross-contaminant background noise. Researchers can explore our full range of test compounds in the catalog of research peptides.
Synthetic oxytocin is supplied as a lyophilized (freeze-dried) powder under vacuum or inert argon gas to preserve chemical stability. To prevent moisture condensation during handling, vials must be allowed to equilibrate to room temperature before opening. For reconstitution in laboratory settings, sterile bacteriostatic water, sterile 0.9% sodium chloride, or laboratory-grade phosphate-buffered saline (PBS, pH 7.4) should be added gently along the inner glass wall of the vial.
Aggressive agitation or vortexing should be avoided, as mechanical shear stress can disrupt tertiary peptide structure or induce aggregation; gentle manual rotation ensures complete dissolution. Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, which degrade the disulfide bridge. Stored at $-20^\circ\text{C}$ or $-80^\circ\text{C}$, reconstituted aliquots remain stable for extended analytical series. Detailed calculations for lab preparations are available in our peptide reconstitution guide.
PX1 Research maintains rigorous quality assurance protocols specifically calibrated for institutional, academic, and industrial research laboratories. Every batch of synthetic oxytocin is manufactured in GMP-compliant facilities adhering to ISO 9001 and ISO 17025 standards. We mandate independent third-party testing for every single production lot, verifying that no peptide leaves our USA facilities without validated RP-HPLC chromatograms, mass spectrometry reports, and LAL endotoxin data.
By enforcing batch-to-batch consistency and providing complete lot traceability, PX1 Research eliminates reagent variability in preclinical experimentation. Orders ship directly from our California and Arizona logistics hubs with same-day dispatch (Monday through Friday), ensuring optimal cold-chain preservation. Research institutions requiring customized container closures, bulk volume reserves, or formal documentation packages can establish direct accounts via our bulk lab accounts portal.
What is the expected purity level on an Oxytocin COA from PX1 Research?
Every lot of Oxytocin supplied by PX1 Research guarantees a chemical purity of $\ge 98.0\%$, as quantified by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) peak integration at 214 nm.
How is the molecular identity of Oxytocin verified in analytical testing?
Molecular identity is confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF MS, verifying that the experimental mass-to-charge ratio matches the theoretical molecular weight of 1007.19 Da.
Why is endotoxin testing critical for Oxytocin used in cell culture research?
Bacterial endotoxins (LPS) cause non-specific activation of Toll-like receptor 4 (TLR4) on cell membranes, inducing inflammatory cytokine release that interferes with oxytocin receptor signaling assays. PX1 Research verifies endotoxin levels are $< 0.01 \text{ EU/\mu g}$ via chromogenic LAL assays.
What solvents are recommended for reconstituting lyophilized Oxytocin for in vitro assays?
Lyophilized Oxytocin is readily soluble in sterile 0.9% normal saline, laboratory-grade phosphate-buffered saline (PBS, pH 7.4), or sterile bacteriostatic water. Solvents should be selected based on the requirements of the downstream cellular or enzymatic assay.
How should reconstituted Oxytocin stock solutions be stored to prevent degradation?
Reconstituted stock solutions should be divided into single-use aliquots and stored at $-20^\circ\text{C}$ or $-80^\circ\text{C}$. Repeated freeze-thaw cycles must be avoided to prevent oxidation of cysteine residues and cleavage of the disulfide ring structure.
What is the key structural difference between Oxytocin and Vasopressin on an HPLC chromatogram?
Oxytocin and Vasopressin differ by two amino acid residues (positions 3 and 8), altering their hydrophobic interaction parameters. On a reverse-phase C18 HPLC column, these structural variations alter retention time ($t_R$), allowing baseline separation of the two compounds.
Does PX1 Research provide lot-specific COAs with every shipment?
Yes. Every shipment includes or provides direct digital access to the lot-specific Certificate of Analysis, containing original unedited RP-HPLC chromatograms, ESI-MS spectra, and LAL endotoxin test results.
Is Oxytocin supplied by PX1 Research suitable for human administration?
No. Oxytocin supplied by PX1 Research is strictly designated for laboratory research use only (RUO), including in vitro cellular assays and preclinical laboratory models. It is not intended for human or animal therapeutic, diagnostic, or clinical application.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.